| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 11.604 | 22.863 | 27.804 | 23.759 | 6.850 | 6.509 | 13.223 | 11.563 |
| Total Income - EUR | - | - | 11.604 | 22.906 | 27.804 | 23.759 | 6.850 | 6.509 | 13.223 | 11.563 |
| Total Expenses - EUR | - | - | 7.976 | 10.956 | 15.298 | 14.596 | 7.671 | 12.723 | 9.686 | 8.787 |
| Gross Profit/Loss - EUR | - | - | 3.627 | 11.950 | 12.506 | 9.163 | -821 | -6.213 | 3.537 | 2.775 |
| Net Profit/Loss - EUR | - | - | 3.511 | 11.721 | 12.227 | 8.938 | -905 | -6.279 | 3.405 | 2.428 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Midanus Med Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 19.534 | 13.931 | 8.969 | 3.759 | 0 | 0 | 0 |
| Current Assets | - | - | 4.031 | 5.583 | 17.528 | 25.688 | 12.555 | 3.864 | 4.489 | 5.661 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 384 | 0 | 0 | 1.134 |
| Cash | - | - | 4.031 | 5.583 | 17.528 | 25.688 | 12.170 | 3.864 | 4.489 | 4.527 |
| Shareholders Funds | - | - | 3.555 | 15.210 | 12.269 | 20.974 | -865 | -7.146 | -3.720 | -1.271 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 476 | 9.907 | 19.190 | 13.682 | 17.178 | 11.010 | 8.209 | 6.931 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Midanus Med Consult Srl